Indication

Chronic pulmonary histoplasmosis

Chronic pulmonary histoplasmosis is a persistent, progressive fungal infection of the respiratory system caused by the inhalation of *Histoplasma capsulatum* spores. Read more about Chronic pulmonary histoplasmosis

1 drugs 1 manufacturers

Advertisement

Drugs that treat it

Common Chronic pulmonary histoplasmosis therapies.

Showing 1–1 of 1 drugs

Filter & compare in the drug finder →Opens the drug finder with Chronic pulmonary histoplasmosis preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic pulmonary histoplasmosis.

Chronic pulmonary histoplasmosis is a persistent, progressive fungal infection of the respiratory system caused by the inhalation of *Histoplasma capsulatum* spores.

This clinical entity predominantly affects older adults and individuals with pre-existing structural lung diseases, particularly emphysema or chronic obstructive pulmonary disease.

Pathophysiologically, the organism colonizes abnormal lung spaces, prompting sustained necrotizing inflammation, pulmonary fibrosis, and progressive apical or upper-lobe cavitation that closely mimics pulmonary tuberculosis.

Clinically, affected patients experience an insidious, prolonged illness characterized by chronic productive cough, hemoptysis, dyspnea, low-grade fevers, night sweats, fatigue, and substantial weight loss, which can lead to progressive loss of lung volume and respiratory failure if left unmanaged.

Personalize your experience

Follow Chronic pulmonary histoplasmosis and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it